Pegoraro, Anna
De Marchi, Elena
Ferracin, Manuela http://orcid.org/0000-0002-1595-6887
Orioli, Elisa
Zanoni, Michele
Bassi, Cristian
Tesei, Anna http://orcid.org/0000-0002-8351-5952
Capece, Marina http://orcid.org/0000-0002-7624-8059
Dika, Emi http://orcid.org/0000-0003-3186-2861
Negrini, Massimo
Di Virgilio, Francesco http://orcid.org/0000-0003-3566-1362
Adinolfi, Elena http://orcid.org/0000-0001-8129-9929
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG16812, IG22837)
Article History
Received: 3 August 2021
Revised: 14 October 2021
Accepted: 29 October 2021
First Online: 16 November 2021
Competing interests
: FDV is a member of the Scientific Advisory Board of Biosceptre Ltd., a Biotech developing P2X7R-targeted therapies. The remaining authors declare no competing interests.